Cerus reported $-13.51M in EBITDA for its fiscal quarter ending in March of 2023.





Ebitda Change Date
GRIFOLS EUR 473M 120M Jun/2026
Haemonetics USD 96.17M 91.87M Jun/2026
Neogen USD 45.4M 2.8M Mar/2026
OraSure Technologies USD -17.7M 4.06M Dec/2025
Plus Therapeutics USD -4.4M 2.94M Sep/2025
Quidel USD 129.3M 20.6M Jun/2026
STAAR Surgical USD 20M 387K Jun/2026
Terumo JPY 116.67B 58.79B Jun/2026